Integrating skin color assessments into clinical practice and research: review of current approaches
Skin color classification can have importance in skin health, pigmentary disorders, and oncologic condition assessments. It is also critical for evaluating disease course and response to a variety of therapeutic interventions and aids in accurate classification of participants in clinical research studies. A panel of dermatologists conducted a literature review to assess the strengths and limitations of existing classification scales, as well as to compare their preferences and utilities. We identified 17 skin classification systems utilized in dermatologic settings. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 8, 2024 Category: Dermatology Authors: Valerie Harvey, Andrew Alexis, Chidubem A.V. Okeke, Lynn McKinley-Grant, Susan C. Taylor, Seemal R. Desai, Tarannum Jaleel, Candice R. Heath, Sewon Kang, Neelam Vashi, Jenna Lester, Rebecca Vasquez, Michelle Rodrigues, Nada Elbuluk, Iltefat Hamzavi, Shawn Source Type: research

Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 8, 2024 Category: Dermatology Authors: Heather A. Brandling-Bennett, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Su Source Type: research

Clinical characteristics and symptom progression of dermatomyositis subtypes: a retrospective analysis of a prospective database
Disease characteristics of classic dermatomyositis (DM) and clinically amyopathic DM (CADM) are well-established, but there exists limited knowledge on disease progression of these subtypes. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 8, 2024 Category: Dermatology Authors: Rachita Pandya, Julianne Kleitsch, Darosa Lim, Victoria P. Werth Source Type: research

Efficient and economical observation method for demodex mites
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 8, 2024 Category: Dermatology Authors: Shufen Wang, Fangfang Bao Source Type: research

Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study
Crisaborole ointment, 2%, is a nonsteroidal topical phosphodiesterase 4 inhibitor approved for the treatment of mild-to-moderate atopic dermatitis. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 8, 2024 Category: Dermatology Authors: Jonathan I. Silverberg, Robert S. Kirsner, David J. Margolis, Michael Tharp, Daniela E. Myers, Karen Annis, Daniela Graham, Chuanbo Zang, Bonnie L. Vlahos, Paul Sanders Tags: Original article Source Type: research

Treatment for Central Centrifugal Cicatricial Alopecia - Delphi Consensus Recommendations
There is no established standard of care for treating central centrifugal cicatricial alopecia (CCCA), and treatment approaches vary widely. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 8, 2024 Category: Dermatology Authors: Tiaranesha Jackson, Yacine Sow, Jewell Dinkins, Crystal Aguh, Katherine Omueti Ayoade, Victoria Barbosa, Cheryl Burgess, Valerie Callender, George Cotsarelis, Pearl Grimes, Valerie Harvey, Chesahna Kindred, Jenna Lester, Kristen Lo Sicco, Tiffany Mayo, Am Source Type: research

Associations Between D-irAE Morphologies and Systemic Immunomodulatory/Immunosuppressive Treatment, a Large Retrospective Cohort Study
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 8, 2024 Category: Dermatology Authors: Rachel M. Reardon, Katherine L. Perlman, Maria S. Asdourian, Nishi Shah, Ted V. Jacoby, Leah L. Thompson, Kerry L. Reynolds, Yevgeniy R. Semenov, Steven T. Chen Source Type: research

Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation
For psoriatic patients who need to receive non-live or live vaccines, evidence-based recommendations are needed regarding whether to pause or continue systemic therapies for psoriasis and/or psoriatic arthritis. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 6, 2024 Category: Dermatology Authors: Vipawee S. Chat, Christoph T. Ellebrecht, Paige Kingston, Stacie Bell, George Gondo, Kelly M. Cordoro, Seemal R. Desai, Kristina C. Duffin, Steven R. Feldman, Amit Garg, Joel M. Gelfand, Dafna Gladman, Lawrence J. Green, Johann Gudjonsson, George Han, Jas Source Type: research

Patterns of metastasis from a multicenter cohort of metastatic basal cell carcinoma
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 6, 2024 Category: Dermatology Authors: Morgan Groover, Neha Gupta, Emily Granger, Vernon J. Forrester, Emily J. Anstadt, William Su, Lauren Heusinkveld, John N. Lukens, Ann W. Silk, Jonathan D. Schoenfeld, Shlomo A. Koyfman, Allison T. Vidimos, Emily S. Ruiz Source Type: research

Association of atopic dermatitis with emotional and behavioral problems in childhood
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 4, 2024 Category: Dermatology Authors: Emily Z. Ma, Stephen R. Hooper, Paige L. Seegan, Joy Wan Source Type: research

Combination Therapy with Imiquimod and 5-Fluorouracil Cream for The Treatment of Actinic Keratoses, a Prospective Open-Label Non-Randomized Uncontrolled Pilot Trial
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 3, 2024 Category: Dermatology Authors: R. Maxwell Regester, Amy C. Cannella, Julianna Hirz, Brain Sayles, Stacie Schlange, Amy Rau, Harlan R. Sayles, Anthony J. Griess Source Type: research

Infective endocarditis is the leading cause of infection-associated cutaneous vasculitis: A single academic center dermatology consultant experience
To the Editor: Cutaneous vasculitis (CV) has diverse manifestations and etiologies —infectious etiologies are common in children whereas idiopathic or underlying systemic conditions are common in adults.1 Infective endocarditis (IE) can cause CV, however, the lack of pathognomonic cutaneous findings makes this diagnosis challenging.2 Importantly, competing etiologies complicate management, as empiric treatments (eg, immunosuppression for infectious etiologies) can be fatal. To investigate the observation that many patients with CV had IE, we conducted a single-institution retrospective study from 2018 to 2023 to characte...
Source: Journal of the American Academy of Dermatology - February 2, 2024 Category: Dermatology Authors: Jordan Phillipps, Carine Lama, John Strickley, Amy Musiek Tags: Research letter Source Type: research

Infective Endocarditis Is the Leading Cause of Infection-Associated Cutaneous Vasculitis - A Single Academic Center Dermatology Consultant Experience
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 2, 2024 Category: Dermatology Authors: Jordan Phillipps, Carine Lama, John Strickley, Amy Musiek Source Type: research

This Month in JAAD International - April 2024
This month in JAAD International, Egeberg et  al1 discuss the high rate of adverse events from chronic topical steroid use for chronic hand eczema. Of the nearly 1300 patients with hand eczema in the Danish Skin Cohort, 724 provided information about adverse events associated with topical steroid use. The results of this study were striking, with 64.1% reporting skin atrophy, suggesting a significant burden for topical steroid use. The authors also reported a range of other adverse events,” including pain or stinging and reduced hand dexterity, some of which may be related to underlying diseases. (Source: Journal of the...
Source: Journal of the American Academy of Dermatology - February 1, 2024 Category: Dermatology Authors: Jonathan Kantor Tags: This month in Source Type: research

This Month in JAAD International: April 2024: Topical steroid adverse effects and patient advocacy
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 1, 2024 Category: Dermatology Authors: Jonathan Kantor Source Type: research